228 related articles for article (PubMed ID: 25631065)
1. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database.
Wang J; Sun Y; Bertagnolli MM
Ann Surg Oncol; 2015 Sep; 22(9):2965-71. PubMed ID: 25631065
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
3. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal.
Röcken C; Behrens HM
Eur J Cancer; 2015 Mar; 51(5):577-86. PubMed ID: 25682192
[TBL] [Abstract][Full Text] [Related]
4. Survival Rates for Patients with Resected Gastric Adenocarcinoma Finally have Increased in the United States.
Arsoniadis EG; Marmor S; Diep GK; Hui JYC; Jensen EH; Tuttle TM
Ann Surg Oncol; 2017 Oct; 24(11):3361-3367. PubMed ID: 28699133
[TBL] [Abstract][Full Text] [Related]
5. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
6. Asian gastric cancer patients show superior survival: the experiences of a single Australian center.
Chen Y; Haveman JW; Apostolou C; Chang DK; Merrett ND
Gastric Cancer; 2015 Apr; 18(2):256-61. PubMed ID: 24858392
[TBL] [Abstract][Full Text] [Related]
7. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
8. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity.
Schwarz RE; Zagala-Nevarez K
Eur J Surg Oncol; 2002 Apr; 28(3):214-9. PubMed ID: 11944952
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
10. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
[TBL] [Abstract][Full Text] [Related]
11. Race influences stage-specific survival in gastric cancer.
Howard JH; Hiles JM; Leung AM; Stern SL; Bilchik AJ
Am Surg; 2015 Mar; 81(3):259-67. PubMed ID: 25760201
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
13. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
[TBL] [Abstract][Full Text] [Related]
14. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.
Chu X; Yang ZF
World J Surg Oncol; 2015 Jun; 13():192. PubMed ID: 26026805
[TBL] [Abstract][Full Text] [Related]
15. Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer.
Mueller JL; Kim DH; Stapleton S; Cauley CE; Chang DC; Park CH; Song KY; Mullen JT
Gastric Cancer; 2019 May; 22(3):446-455. PubMed ID: 30167904
[TBL] [Abstract][Full Text] [Related]
16. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
17. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
18. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
Schmidt B; Chang KK; Maduekwe UN; Look-Hong N; Rattner DW; Lauwers GY; Mullen JT; Yang HK; Yoon SS
Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
[TBL] [Abstract][Full Text] [Related]
19. Estimates of conditional survival in gastric cancer reveal a reduction of racial disparities with long-term follow-up.
Luyimbazi D; Nelson RA; Choi AH; Li L; Chao J; Sun V; Hamner JB; Kim J
J Gastrointest Surg; 2015 Feb; 19(2):251-7. PubMed ID: 25421357
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database.
Lin J; Qiu M; Xu R; Dobs AS
Oncotarget; 2015 Oct; 6(32):33935-43. PubMed ID: 26375551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
